知镜 Cognispect · 医学文献与研究工作台

Development and validation of an adjunctive diagnostic tool for Canadian CT head rule-positive patients: a pilot study.

Lampros M, Symeou S, Vlachodimitropoulou L, Alexiou G, Voulgaris S.
Neurosurgical review · 2026-11-09 · PMID 43000583

文献摘要

Mild traumatic brain injury (mTBI) is among the most frequent causes of emergency department visits worldwide. Although the Canadian CT Head Rule (CCHR) and similar algorithms provide high sensitivity for detecting clinically significant injuries, their limited specificity results in overuse of computed tomography (CT), with associated costs, radiation exposure, and resource strain. This study investigated the value of routine laboratory biomarkers as adjunctive tools for CT decision-making in CCHR-positive patients with mTBI. Inclusion parameters were based primarily on their clinical significance and statistical performance. Two cohorts from a single tertiary center were analyzed: a development cohort of 110 patients and a temporal validation cohort of 127 patients recruited at the same institution during an earlier period. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and glucose-to-potassium ratio (GPR) were significantly elevated in CT-positive cases. A multivariable logistic regression model including NLR, PLR, glucose, loss of consciousness, and repeated vomiting achieved strong performance in the original cohort (AUC 0.94, 95% CI 0.89-0.98; sensitivity 94.7%, 95% CI 88.1-97.7; specificity 62.5%, 95% CI 38.6-81.5; accuracy 90.0%; optimism-corrected AUC 0.90 on bootstrap internal validation). In the validation cohort the model retained high sensitivity (92.2%, 95% CI 83.4-96.2) but showed significantly lower overall discrimination (AUC 0.78, 95% CI 0.67-0.84). These findings suggest that combining simple, widely available biomarkers with established clinical criteria may provide a practical, low-cost triage tool for optimizing CT use in mild TBI, especially in resource-limited settings. Because the development cohort was recruited among high-risk patients and because the second cohort provides temporal rather than external validation, these results are preliminary and require confirmation in a prospective multicentre cohort.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。